GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Delta-Fly Pharma Inc (TSE:4598) » Definitions » Scaled Net Operating Assets

Delta-Fly Pharma (TSE:4598) Scaled Net Operating Assets : -0.08 (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Delta-Fly Pharma Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Delta-Fly Pharma's operating assets for the quarter that ended in Dec. 2023 was 円52.39 Mil. Delta-Fly Pharma's operating liabilities for the quarter that ended in Dec. 2023 was 円91.00 Mil. Delta-Fly Pharma's Total Assets for the quarter that ended in Sep. 2023 was 円490.78 Mil. Therefore, Delta-Fly Pharma's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2023 was -0.08.


Delta-Fly Pharma Scaled Net Operating Assets Historical Data

The historical data trend for Delta-Fly Pharma's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Delta-Fly Pharma Scaled Net Operating Assets Chart

Delta-Fly Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Scaled Net Operating Assets
Get a 7-Day Free Trial 0.01 0.03 -0.01 -0.02 -0.04

Delta-Fly Pharma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.06 -0.06 0.01 -0.04 -0.08

Competitive Comparison of Delta-Fly Pharma's Scaled Net Operating Assets

For the Biotechnology subindustry, Delta-Fly Pharma's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Delta-Fly Pharma's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Delta-Fly Pharma's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Delta-Fly Pharma's Scaled Net Operating Assets falls into.



Delta-Fly Pharma Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Delta-Fly Pharma's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Mar. 2023 )
=(Operating Assets (A: Mar. 2023 )-Operating Liabilities (A: Mar. 2023 ))/Total Assets (A: Mar. 2022 )
=(62.476-115.619)/1324.352
=-0.04

where

Operating Assets(A: Mar. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=906.817 - 844.341
=62.476

Operating Liabilities(A: Mar. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=115.619 - 0 - 0
=115.619

Delta-Fly Pharma's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2023 )
=(Operating Assets (Q: Dec. 2023 )-Operating Liabilities (Q: Dec. 2023 ))/Total Assets (Q: Sep. 2023 )
=(52.394-91.002)/490.779
=-0.08

where

Operating Assets(Q: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=1780.153 - 1727.759
=52.394

Operating Liabilities(Q: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=91.002 - 0 - 0
=91.002

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Delta-Fly Pharma Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Delta-Fly Pharma's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Delta-Fly Pharma (TSE:4598) Business Description

Traded in Other Exchanges
N/A
Address
Miyajima Kinno 37-5, Tokushima Prefecture, Kawauchi Town, Tokushima, JPN, 771-0116
Delta-Fly Pharma Inc is a Japan-based company mainly engaged in the discovery and development of gentle anti-cancer agents with module technology.

Delta-Fly Pharma (TSE:4598) Headlines

No Headlines